MedPath

BBP-711

Generic Name
BBP-711
Drug Type
Small Molecule

Overview

BBP-711 is a glycolate oxidase inhibitor.

Background

BBP-711 is a glycolate oxidase inhibitor.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Completed
Posted: 2021/05/07
Sponsor:
Cantero Therapeutics...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath